Abiopharma

JOHNSTON EUGENE M 🔴 sold 5.0K shares of MANGOCEUTICALS, INC. (MGRX) at $1.20 Transaction Date: Dec 09, 2025 | Filing ID: 027238

Director Stuka Paul 🟢 acquired 5.1K shares of InspireMD, Inc. (NSPR) at $1.81 Transaction Date: Dec 09, 2025 | Filing ID: 027239

Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

(99% Neutral) Veeva Systems Inc. (VEEV) Announces New Board Appointment

Director SPERLING SCOTT M 🔴 sold 4.4K shares of THERMO FISHER SCIENTIFIC INC. (TMO) Transaction Date: Dec 10, 2025 | Filing ID: 000182

Tenaya Therapeutics Announces Proposed Public Offering

📋 Chopra Daveen (Officer) plans to sell 2K shares of Edwards Lifesciences Corp (at $84.38 each, total $169K) Filed: Dec 11, 2025 | ID: 001526

Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC

Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs

Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy

New Form SCHEDULE 13G - CRESCENT BIOPHARMA, INC. Filed: 2025-12-11 AccNo: 0001193125-25-315863 Size: 12 KB

New Form ARS - REGIONAL HEALTH PROPERTIES, INC Filed: 2025-12-11 AccNo: 0001539497-25-003252 Size: 1 MB